Acute Decompensated Heart Failure: Quick Reference Photocard
IMMEDIATE ASSESSMENT & STABILIZATION
Rapidly classify hemodynamic profile: "Wet vs Dry" and "Warm vs Cold" 1
Initial Actions (First Minutes)
- Oxygen therapy: Target SpO2 94-96% with face mask or CPAP 2
- IV access and continuous monitoring (ECG, BP, SpO2) 2
- Obtain: ECG, troponin, BNP/NT-proBNP, chest X-ray, basic metabolic panel 1, 3
- Echocardiography as soon as possible 2
TREATMENT ALGORITHM
1️⃣ DECONGESTION (Primary Goal)
IV Loop Diuretics - Start Immediately 1
- Dose: Equal to or GREATER than chronic oral daily dose
- Route: IV bolus or continuous infusion
- Monitor: Daily weights, urine output, electrolytes, renal function 1
If inadequate response 1:
- Increase loop diuretic dose, OR
- Add second diuretic (thiazide/metolazone) - CAUTION: hypokalemia risk 2, 1
Refractory congestion 1:
- Consider ultrafiltration (Class IIb)
- Consider CVVH if severe renal dysfunction 2
2️⃣ VASODILATORS (If Hypertensive)
For AHF + Hypertension 2:
- IV nitroglycerin or nitroprusside (Class IIb) 1, 3
- Goal: Rapid BP reduction of 30 mmHg within minutes
- Then: Progressive decrease over hours to pre-crisis values
- DO NOT normalize BP - risks organ hypoperfusion 2
Alternative: Nicardipine for diastolic dysfunction 2
AVOID beta-blockers in acute pulmonary edema (except phaeochromocytoma) 2
3️⃣ SPECIAL SITUATIONS
Low Cardiac Output/Hypotension 3:
- Inotropes (dopamine, dobutamine, milrinone) ONLY if:
- Documented severe systolic dysfunction
- Low BP with evidence of hypoperfusion
- NOT for normotensive patients (Class III) 3
ACS-Related AHF 2:
- Urgent cardiac catheterization and revascularization (Class I) 2
- Consider IABP for cardiogenic shock 2
Aortic Dissection 2:
- Immediate surgical consultation
- TEE for valve assessment
- Speed is vital 2
CRITICAL PITFALLS TO AVOID
❌ DO NOT use inotropes in normotensive patients without hypoperfusion 3
❌ DO NOT normalize BP in hypertensive crisis - causes organ damage 2
❌ DO NOT stop beta-blockers abruptly unless cardiogenic shock 4
❌ DO NOT combine ACE-I + ARB + spironolactone (hyperkalemia risk) 4
CONTINUE GUIDELINE-DIRECTED MEDICAL THERAPY
Beta-blockers: Continue unless hemodynamically unstable or cardiogenic shock 4, 1
ACE-I/ARB: Continue if stable 1
Initiate at low dose before discharge if not already on therapy 1
MONITORING REQUIREMENTS
Daily: Weights, I/O, electrolytes, renal function 1
Continuous: Telemetry, vital signs 2
Consider invasive monitoring (PA catheter) if 3:
- Persistent symptoms despite therapy
- Uncertain volume/perfusion status
- Worsening renal function
- Requiring parenteral vasoactive agents
DISCHARGE CRITERIA
✓ Complete decongestion achieved 5
✓ Precipitants identified and treated 5
✓ GDMT optimized and tolerated 1, 5
✓ VTE prophylaxis given (unless contraindicated) 1
✓ Follow-up scheduled within 7-14 days 1
✓ Telephone follow-up within 3 days 1
KEY COMORBIDITY ADJUSTMENTS
Renal Failure: May need CVVH + inotrope combination 2
Hypertension: Facilitates early GDMT uptitration 6
Atrial Fibrillation: Anticoagulation (INR 2-3) mandatory 4
Diabetes: Close glucose monitoring with diuretics 2